Latest Agenus News & Updates

See the latest news and media coverage for Agenus. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Agenus

Clinical-stage biotechnology company developing cancer immunotherapies

agenusbio.com
Headquarters
Lexington, United States
Founded year
1994
Company type
Public company
Number of employees
200–500
Industry
Pharmaceuticals

Last updated

Latest news about Agenus

In short: Agenus reported Q2 profit, raised up to $340M for ROBBIN, and posted durable BOT+BAL survival data.

Company announcements

Agenus

Agenus files Form S-3 with the SEC

The company registered securities via a simplified registration statement dated September 11, 2026. Downloadable formats include PDF and Excel.

Agenus

Agenus presents ovarian cancer survival data at IGCS 2026

The company shares three-year overall survival results for botensilimab plus balstilimab in recurrent ovarian cancer during its virtual poster presentation.

Unlock all announcements with a

Media coverage

Yahoo Finance

Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that a poster evaluating botensilimab (BOT), an Fc-enhanced multifunctional anti-CTLA-4 antibody, in combination with...

Unlock all articles with a

Never miss news about Agenus

Track Agenus and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Agenus competitors & trending companies

Browse news for competitors to Agenus and other trending companies.